Literature DB >> 12135828

A user perspective on type 1 diabetes: sense of illness, search for freedom and the role of the pharmacy.

Lotte Stig Haugbølle1, Kristina Devantier, Bente Frydenlund.   

Abstract

The aim of the study described in this article was to explore young type 1 diabetic patients self-perceived knowledge, perception of diabetes, ways of regulating insulin intake, purpose of behaviour and attitudes about and requirements of the pharmacy. The interest group for utilising this study comprises pharmacy practice researchers and staff at community pharmacies who plan to focus on type 1 diabetic patients. The study, based on 10 semi-structured qualitative interviews, showed how young type 1 diabetic patients can be divided into three different groups based on the way they regulate their insulin intake. These groups are described and discussed in detail in the article. What drives the diabetic patients in terms of regulating insulin intake is primarily their experience-based knowledge and their search for freedom.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135828     DOI: 10.1016/s0738-3991(02)00016-2

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  4 in total

1.  Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma--interviewing patients at home.

Authors:  Lotte Stig Haugbølle; Ellen Westh Sørensen
Journal:  Pharm World Sci       Date:  2006-10-26

2.  Consumers' perceptions of community pharmacy in Portugal: a qualitative exploratory study.

Authors:  Afonso M Cavaco; J P Sousa Dias; Ian P Bates
Journal:  Pharm World Sci       Date:  2005-02

3.  Adherence to treatment: practice, education and research in Danish community pharmacy.

Authors:  Lotte S Haugbølle; Hanne Herborg
Journal:  Pharm Pract (Granada)       Date:  2009-03-15

4.  Medication management in the context of mental illness: an exploratory study of young people living in Australia.

Authors:  Sara S McMillan; Victoria Stewart; Amanda J Wheeler; Fiona Kelly; Helen Stapleton
Journal:  BMC Public Health       Date:  2020-07-30       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.